Status, challenges and gaps in antimicrobial resistance surveillance around the world

J Glob Antimicrob Resist. 2021 Jun:25:222-226. doi: 10.1016/j.jgar.2021.03.016. Epub 2021 Apr 15.

Authors

Isabel Frost¹, Geetanjali Kapoor², Jessica Craig³, Daniel Liu², Ramanan Laxminarayan⁴

Affiliations

¹ Center for Disease Dynamics, Economics & Policy, New Delhi, India; Imperial College London, London, UK.
² Center for Disease Dynamics, Economics & Policy, New Delhi, India.
³ Center for Disease Dynamics, Economics & Policy, Washington DC.
⁴ Center for Disease Dynamics, Economics & Policy, New Delhi, India; Center for Disease Dynamics, Economics & Policy, Washington DC; Princeton University, Princeton, NJ, USA.

PMID: 33845163
DOI: 10.1016/j.jgar.2021.03.016

No abstract available

MeSH terms

Anti-Bacterial Agents* / pharmacology
Anti-Bacterial Agents* / therapeutic use
Drug Resistance, Bacterial*
Population Surveillance

Substances

Anti-Bacterial Agents